Request for Information on Promising Practices for Advancing Health Equity for Intersex Individuals; Correction, 10526 [2023-03539]

Download as PDF 10526 Federal Register / Vol. 88, No. 34 / Tuesday, February 21, 2023 / Notices Dated: February 15, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023–03521 Filed 2–17–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Request for Information on Promising Practices for Advancing Health Equity for Intersex Individuals; Correction ACTION: Notice; correction. The Office of the Assistant Secretary for Health published a document in the Federal Register of February 10, 2023, announcing a request for information on Promising Practices for Advancing Health Equity for Intersex Individuals. The document included incorrect information regarding the ADDRESSES section and also SUPPLEMENTARY INFORMATION and also the collection for public comment. FOR FURTHER INFORMATION CONTACT: Adrian Shanker, Adrian.shanker@ hhs.gov or by phone at (202) 961–6483. SUPPLEMENTARY INFORMATION: lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: Correction In the Federal Register of February 10, 2023, in FR Doc 2023–02826, on page 8876 in the first column, correct the ADDRESSES section to read, ‘‘Please see the supplementary information to view the questions. Comments must be submitted via Regulations.gov. Mailed paper and emailed submissions will not be reviewed.’’ At the second column, tenth line, after the end of the sentence ‘‘conversation therapy.’’ the sentence should continue with the following: ‘‘(efforts to change an individual’s sexual orientation, gender identity, or gender expression, a practice not supported by any credible evidence that has been rejected and disavowed by behavioral health experts and associations). Conversion therapy perpetuates outdated views of gender roles and identities as well as the negative stereotype that being a sexual or gender minority or identifying as LGBTQI+ is an abnormal aspect of human development. Most importantly, it may put young people at risk of serious harm.’’ At the second column, second paragraph to the end of the document is to be replaced as follows: ‘‘Request for Comments on the Report Development on Promising Practices for Advancing Health Equity for Intersex Individuals: The OASH invites input from intersex people, stakeholders throughout the VerDate Sep<11>2014 17:54 Feb 17, 2023 Jkt 259001 scientific research community, clinical and behavioral practice communities, patient and family advocates, school and university-based campus health care providers, persons from rural and frontier areas, scientific or professional organizations, federal partners, internal HHS stakeholders, and other interested members of the public on the two questions highlighted below. This input will serve as a valuable element in the development of the report, and the community’s time and consideration are highly appreciated. • What do you see as the current clinical/behavioral, research, services, and/or policy gaps that you are hoping this report addresses? • What recent or ongoing research, innovative clinical/behavioral approaches and/or policy actions do you think are important for us to know about as we begin this work? • What are the barriers to intersex individuals receiving clinical/ behavioral care? Are there innovative policies or practices that overcome such barriers? • What are the social factors that impact clinical/behavioral care (e.g., the medical community’s perceptions or biases around sex/gender) and how do these impact delivery and quality of care for intersex individuals? • What promising practices for advancing health equity for intersex individuals should we be aware of? Responses to this RFI are voluntary. Do not include any personally identifiable, proprietary, classified, confidential, trade secret, or sensitive information in your response. The responses will be reviewed by OASH staff, and individual feedback will not be provided to any responder. The Government will use the information submitted in response to this RFI at its discretion. The Government reserves the right to release comments publicly and to use any submitted information on public HHS websites; in reports; in summaries of the state of the science; in any possible resultant solicitation(s), grant(s), or cooperative agreement(s); or in the development of future funding opportunity announcements. This RFI is for information and planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States Federal Government, the HHS, or individual HHS Agencies and Offices to provide support for any ideas identified in response to it. The Federal Government will not pay for the preparation of any information submitted or for the Government’s use of such information. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 No basis for claims against the U.S. Government shall arise as a result of a response to this RFI or from the Government’s use of such information. Additionally, the Government cannot guarantee the confidentiality of the information provided.’’ Dated: February 15, 2023. Rachel L. Levine, Assistant Secretary for Health. [FR Doc. 2023–03539 Filed 2–17–23; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Chemistry, Biochemistry and Biophysics A. Date: March 14–15, 2023. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Vandana Kumari, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–3290, vandana.kumari@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: HEAL Initiative—Helping to End Addiction Long-term. Date: March 14, 2023. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David Erik Pollio, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1006F, Bethesda, MD 20892, (301) 594–4002, polliode@csr.nih.gov. E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 88, Number 34 (Tuesday, February 21, 2023)]
[Notices]
[Page 10526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03539]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Request for Information on Promising Practices for Advancing 
Health Equity for Intersex Individuals; Correction

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Office of the Assistant Secretary for Health published a 
document in the Federal Register of February 10, 2023, announcing a 
request for information on Promising Practices for Advancing Health 
Equity for Intersex Individuals. The document included incorrect 
information regarding the Addresses section and also Supplementary 
Information and also the collection for public comment.

FOR FURTHER INFORMATION CONTACT: Adrian Shanker, [email protected] 
or by phone at (202) 961-6483.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of February 10, 2023, in FR Doc 2023-02826, 
on page 8876 in the first column, correct the Addresses section to 
read, ``Please see the supplementary information to view the questions. 
Comments must be submitted via Regulations.gov. Mailed paper and 
emailed submissions will not be reviewed.''
    At the second column, tenth line, after the end of the sentence 
``conversation therapy.'' the sentence should continue with the 
following: ``(efforts to change an individual's sexual orientation, 
gender identity, or gender expression, a practice not supported by any 
credible evidence that has been rejected and disavowed by behavioral 
health experts and associations). Conversion therapy perpetuates 
outdated views of gender roles and identities as well as the negative 
stereotype that being a sexual or gender minority or identifying as 
LGBTQI+ is an abnormal aspect of human development. Most importantly, 
it may put young people at risk of serious harm.''
    At the second column, second paragraph to the end of the document 
is to be replaced as follows: ``Request for Comments on the Report 
Development on Promising Practices for Advancing Health Equity for 
Intersex Individuals: The OASH invites input from intersex people, 
stakeholders throughout the scientific research community, clinical and 
behavioral practice communities, patient and family advocates, school 
and university-based campus health care providers, persons from rural 
and frontier areas, scientific or professional organizations, federal 
partners, internal HHS stakeholders, and other interested members of 
the public on the two questions highlighted below. This input will 
serve as a valuable element in the development of the report, and the 
community's time and consideration are highly appreciated.
     What do you see as the current clinical/behavioral, 
research, services, and/or policy gaps that you are hoping this report 
addresses?
     What recent or ongoing research, innovative clinical/
behavioral approaches and/or policy actions do you think are important 
for us to know about as we begin this work?
     What are the barriers to intersex individuals receiving 
clinical/behavioral care? Are there innovative policies or practices 
that overcome such barriers?
     What are the social factors that impact clinical/
behavioral care (e.g., the medical community's perceptions or biases 
around sex/gender) and how do these impact delivery and quality of care 
for intersex individuals?
     What promising practices for advancing health equity for 
intersex individuals should we be aware of?
    Responses to this RFI are voluntary. Do not include any personally 
identifiable, proprietary, classified, confidential, trade secret, or 
sensitive information in your response. The responses will be reviewed 
by OASH staff, and individual feedback will not be provided to any 
responder. The Government will use the information submitted in 
response to this RFI at its discretion. The Government reserves the 
right to release comments publicly and to use any submitted information 
on public HHS websites; in reports; in summaries of the state of the 
science; in any possible resultant solicitation(s), grant(s), or 
cooperative agreement(s); or in the development of future funding 
opportunity announcements.
    This RFI is for information and planning purposes only and should 
not be construed as a solicitation for applications or proposals, or as 
an obligation in any way on the part of the United States Federal 
Government, the HHS, or individual HHS Agencies and Offices to provide 
support for any ideas identified in response to it. The Federal 
Government will not pay for the preparation of any information 
submitted or for the Government's use of such information.
    No basis for claims against the U.S. Government shall arise as a 
result of a response to this RFI or from the Government's use of such 
information. Additionally, the Government cannot guarantee the 
confidentiality of the information provided.''

    Dated: February 15, 2023.
Rachel L. Levine,
Assistant Secretary for Health.
[FR Doc. 2023-03539 Filed 2-17-23; 8:45 am]
BILLING CODE 4150-28-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.